Caplin Point Labs schedules AGM with ₹8 per share dividend payout

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Total dividend for FY26 stands at ₹8 per equity share, including a recommended final dividend of ₹4
  • Dr. Sridhar Ganesan seeks re-appointment as Managing Director for a two-year term until August 2028
  • Mr. D. Muralidharan appointed as Whole-Time Director while retaining his role as CFO
  • Chairman Mr. C. C. Paarthipan seeks approval to continue in office after attaining age 75
  • The 35th AGM is scheduled for September 25, 2026, via video conferencing
powered bylight_fuzz_icon
49981233

*this image is generated using AI for illustrative purposes only.

Caplin Point Laboratories has scheduled its 35th Annual General Meeting for September 25, 2026. The meeting will be held via Video Conferencing or Other Audio-Visual Means at 10:00 am.

The Board has recommended a final dividend of ₹4 per equity share of face value ₹2 each. This adds to the interim dividend of ₹4 already declared, bringing the total dividend for FY26 to ₹8 per share (400%). Shareholders on record as of September 18, 2026 will be eligible for the final payout.

Key Agenda Items

The meeting agenda focuses on adopting financial statements and approving significant board-level appointments and continuations.

Board Appointments and Continuations

Three special resolutions require shareholder approval regarding the company's leadership structure:

  • Re-appointment of Managing Director: Dr. Sridhar Ganesan (DIN: 06819026) seeks re-appointment as Managing Director for two years, from August 25, 2026, to August 24, 2028. His annual salary is set at ₹55,20,000, with additional perquisites subject to Schedule V limits.
  • Continuation of Chairman: Mr. C. C. Paarthipan (DIN: 01218784) seeks approval to continue as Chairman and Non-Executive, Non-Independent Director despite attaining the age of 75 during his tenure. He receives no remuneration.
  • Appointment of Whole-Time Director: Mr. D. Muralidharan (DIN: 08301904), currently the Chief Financial Officer, is appointed as Whole-Time Director for two years starting August 12, 2026. His annual salary is fixed at ₹62,37,600. He will continue to serve as CFO without additional compensation.

E-Voting Details

Remote e-voting opens on September 22, 2026, at 9:00 am and closes on September 24, 2026, at 5:00 pm. The cut-off date for determining voting eligibility is September 18, 2026. Members can vote via the National Securities Depository Limited platform.

Historical Stock Returns for Caplin Point Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+4.58%+13.06%+13.04%+70.06%+33.73%+285.24%

How might the promotion of the CFO to Whole-Time Director influence Caplin Point's strategic financial planning and capital allocation for FY27?

What are the potential implications for corporate governance and leadership stability given the Chairman's continuation past the age of 75?

Will the consistent dividend payout of ₹8 per share signal sustained profitability, or does it reflect limited high-growth investment opportunities for the company?

Caplin Point Laboratories
View Company Insights
View All News
like16
dislike

Caplin Point Laboratories files FY26 BRSR report with stock exchanges

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Caplin Point Laboratories files FY26 BRSR report covering domestic units and subsidiaries
  • Workforce totals 2,877 employees with 39% female representation
  • Total energy consumption falls 1.4% YoY to 1,97,534.46 GJ
  • Scope 1 and Scope 2 emissions recorded at 3,524.56 and 13,875.64 tCO2e respectively
  • Limited assurance provided by M/s Alagar & Associates LLP on core indicators
powered bylight_fuzz_icon
49969604

*this image is generated using AI for illustrative purposes only.

Caplin Point Laboratories has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026, to the Bombay Stock Exchange and the National Stock Exchange of India. The disclosure covers sustainability metrics across its domestic manufacturing units and subsidiaries, including Caplin Steriles Limited and Caplin One Labs Limited.

The company reported that its products are exclusively meant for export markets, with operations spanning 57 countries. The reporting boundary includes all units of Caplin Point Laboratories Limited and its Indian subsidiaries, while overseas subsidiaries were excluded as they are primarily involved in marketing activities.

Workforce and Governance

As of March 31, 2026, the company employed a total of 2,877 permanent and non-permanent employees. The workforce composition included 1,745 males (61%) and 1,132 females (39%). Additionally, there were 2,578 workers, comprising 1,466 males (57%) and 1,112 females (43%).

The turnover rate for permanent employees stood at 36.93% in FY26, up from 32.52% in FY25 and 26.9% in FY24. The Board of Directors comprises 24 members, with women representing 12.50% of the total. Key Management Personnel included 11 individuals, with female representation at 27.27%.

Environmental Metrics

The company disclosed significant environmental data for FY26:

Metric FY26 FY25
Total Energy Consumption (GJ) 1,97,534.46 2,00,346.76
Renewable Energy Share 42.8% 44.3%
Water Withdrawal (KL) 78,235.22 55,116.38
Scope 1 Emissions (tCO2e) 3,524.56 3,588.82
Scope 2 Emissions (tCO2e) 13,875.64 13,768.28

Total waste generated increased to 374.07 metric tonnes in FY26 from 350.97 metric tonnes in FY25. Of this, 53.81 metric tonnes were recycled or recovered through various operations.

What the Numbers Show

The data reveals a divergence between energy consumption and intensity metrics. While total energy consumption decreased slightly by 1.4% year-on-year, the energy intensity per rupee of turnover improved significantly, dropping to 0.0000009 GJ/Rupee from 0.0000104 GJ/Rupee in the prior year. This suggests that revenue growth outpaced energy usage during the period.

Assurance and Compliance

M/s Alagar & Associates LLP provided limited assurance on the BRSR Core disclosures. The company reported no fines, penalties, or material non-compliances with environmental laws during the reporting period. It also confirmed zero instances of sexual harassment complaints under the POSH Act and no data breaches involving customer personally identifiable information.

Historical Stock Returns for Caplin Point Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+4.58%+13.06%+13.04%+70.06%+33.73%+285.24%

How might the rising employee turnover rate of 36.93% impact Caplin Point's operational efficiency and future recruitment costs in a competitive pharma labor market?

What specific strategies will Caplin Point implement to reverse the decline in renewable energy share from 44.3% to 42.8% amidst increasing global ESG scrutiny?

Given the 42% increase in water withdrawal, what infrastructure investments or conservation technologies is the company planning to deploy to mitigate water stress risks?

Caplin Point Laboratories
View Company Insights
View All News
like20
dislike

More News on Caplin Point Laboratories

1 Year Returns:+33.73%